Dual-Chamber Pacemakers Better for Heart Patients

They cost more, but reduce hospitalizations and disability, study finds

Please note: This article was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. And "More information" links may no longer work. Questions about personal health should always be referred to a physician or other health care professional.

En Español

HealthDay Reporter

MONDAY, Jan. 3, 2005 (HealthDayNews) -- Dual-chamber pacemakers may be more expensive than single-chamber models, but they're worth it because they reduce the risk of hospitalization and disability, a new study finds.

"Most people in the United States [who need an artificial pacemaker] receive dual-chamber pacemakers," said study co-author Dr. David J. Cohen, an associate professor of medicine at Harvard Medical School.

But, he added, "The cost effectiveness of dual-chamber pacemakers had not been studied."

The findings appear in the Jan. 4 online issue of Circulation.

For the study, Cohen and his colleagues used four years of data from 2,010 patients enrolled in a clinical trial who needed a pacemaker because of a condition called sick sinus syndrome, in which the sinus node -- the heart's "natural" pacemaker -- becomes defective. Then they projected the trial findings over a patient's lifetime.

People with sick sinus syndrome have very slow heartbeats and are prone to chest pain, dizziness, fainting and fatigue.

An artificial pacemaker is a small, battery-operated device that helps the heart beat in a more regular rhythm.

Cohen's team found the dual-chamber pacemakers reduced the risk of hospitalization and disability, and the added cost was very favorable over a patient's lifetime.

"The dual-chamber pacemaker stimulates both the upper and lower chambers of the heart and more closely approximates the normal heartbeat," Cohen said. Single-chamber models stimulate a single chamber, "which is sufficient to keep blood pumping and keep the person from passing out but in some patients is not tolerated."

Cohen said 1,014 patients had a dual-chamber pacemaker and the other 996 had single-chamber devices. The median age was 74, and 48 percent of the people were women.

Dual-chamber pacemakers cost about $3,000 more than single-chamber devices during the first four years of the study. Over a lifetime, the dual-chamber models had a cost of $59,104; the single-chamber models, $58,160, Cohen said.

Patients with dual-chamber devices were less likely to be hospitalized with heart failure than those who got the single-chamber models. And those with the dual-chamber models had a slightly lower risk of death or stroke, along with much better results on several measures of health-related quality of life.

"Dual-chamber pacemakers, at their current cost, looked like a reasonable value when we looked at it over the lifetime," Cohen said, adding the benefits increased over time after the initial four-year data. "Over the first four years, it looked like a borderline investment," he said.

Cohen and his colleagues found that during the first four years, the dual-chamber pacemakers increased "quality adjusted life expectancy" by 0.013 years per patient at an incremental "cost-effectiveness ratio" of $53,000 per quality adjusted year of life gained.

"In the U.S., treatments that have cost-effectiveness ratios of less than $50,000 are generally considered favorable," he said.

But the dual-chambers' cost effectiveness improved when the researchers projected the results over a lifetime. They estimated the dual-chamber models would increase quality adjusted life expectancy by 0.14 years with an incremental cost-effectiveness ratio of about $6,800 per quality adjusted year of life gained. "That would be a very favorable ratio," Cohen said. It would be comparable, he added, to results from treating severe high blood pressure, or giving statin drugs to lower cholesterol.

Dr. William Weintraub, a professor of medicine at Emory University School of Medicine, called the new research "a very good study and a difficult study to do."

The take-home message for consumers? If you need a pacemaker, get a dual-chamber model. "It is going to make you feel better," Weintraub said.

More information

To learn more about pacemakers, visit the American Heart Association.

SOURCES: David J. Cohen, M.D., associate professor, medicine, Harvard Medical School, Boston; William Weintraub, M.D., professor, medicine, Emory University School of Medicine, Atlanta; Jan. 4, 2005, Circulation online

Last Updated: